Our latest news, insights & events
Congratulations to our client, Silexion Therapeutics Ltd., a clinical-stage, oncology-focused biotechnology company, for closing a business combination with Moringa Acquisition
Silexion Therapeutics Corp Welcome to NASDAQ!
Congratulations to our client Credito IPOs Ltd. for completing the first public RMBS Transaction in Israel. This groundbreaking transaction securitizes
Landmark Public RMBS Transaction in Israel
The FTSE All-World Index arrives to TASE! Our client, Invesco, has just listed its 17th ETF on the Tel Aviv
INVESCO Launches New ETF on the Tel Aviv Stock Exchange
Exciting News from INVESCO! We are thrilled to announce that INVESCO has recently registered three new ETFs on the Tel
Three New ETF Registered in the TASE
Congratulations to Nimrod Kozlovski, Limor Schwartz, Yoni Shrits and to the entire Cytactic team for the closing of a $16M
$16 Million Seed Funding Round for Cytactic Cyber Management!
Exciting News! We’re proud to announce our contribution to the Chambers and Partners Global Practice Guide for Medical Cannabis &
Global Practice Guide for Medical Cannabis & Cannabinoid Regulation in Israel 2024
Congratulations to Highbridge Capital Management and Gamida Cell for their success in securing court-approved creditors’ arrangement plan. This plan will
HighBridge and Gamida Cell Secure Court-Approved Creditors’ Arrangement
Our firm is pleased to represent Glassbox Ltd. in its acquisition by Alicorn VC for approximately USD 150 million. The
Glassbox is being acquired by Alicorn
We are thrilled to announce that our latest article on Tax Controversy has been published in the esteemed Chambers Practice
Tax Controversy 2024
We are pleased to announce our involvement in the execution of a landmark transaction for our client, the Neogames group,
NeoGames partners with Big Brazil for its Caesars Brazil brand
Roy Schöndorf, in his article, provides a comprehensive analysis of the concept of plausibility in the context of the International


